Cynthia Seidel-Dugan
Geen lopende functies
Vermogen: 1 M $ op 31-03-2024
Profiel
Cynthia Seidel-Dugan worked as the Chief Scientific Officer at Potenza Therapeutics, Inc. from 2018 to 2018.
Prior to that, she was the Vice President-Biology at CoStim Pharmaceuticals, Inc. from 2013 to 2014.
Currently, she is the Chief Scientific Officer at Werewolf Therapeutics, Inc. from 2019 to 2024.
Dr. Seidel-Dugan holds a doctorate degree from the University of Pennsylvania and an undergraduate degree from The College of William & Mary.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
02-01-2024 | 164 888 ( 0.39% ) | 1 M $ | 31-03-2024 |
Eerdere bekende functies van Cynthia Seidel-Dugan
Bedrijven | Functie | Einde |
---|---|---|
WEREWOLF THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 29-03-2024 |
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01-12-2018 |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | Corporate Officer/Principal | 01-02-2014 |
Opleiding van Cynthia Seidel-Dugan
University of Pennsylvania | Doctorate Degree |
The College of William & Mary | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
WEREWOLF THERAPEUTICS, INC. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
Potenza Therapeutics, Inc.
Potenza Therapeutics, Inc. BiotechnologyHealth Technology Potenza Therapeutics, Inc. develops oncology programs and mechanisms for tumors detection. It is focusing on the discovery and development of novel immune-oncology therapeutics: molecules that stimulate the power of the immune system to fight cancer. The company was founded by Drew M. Pardoll and Daniel J. Hicklin in 2014 and is headquartered in Cambridge, MA. | Health Technology |
CoStim Pharmaceuticals, Inc.
CoStim Pharmaceuticals, Inc. BiotechnologyHealth Technology CoStim Pharmaceuticals, Inc. operates as a biotech company which develops biologics for oncology indications. It offers therapies which target immune checkpoint inhibitors for novel treatment. The company was founded on February 01, 2013 and is headquartered in Boston, MA. | Health Technology |